Gene&Cell Therapy >> Adcomm votes yes on Leqembi full OK; Merck brings first IRA lawsuit; Special: LGBTQ+ leaders; Best-paying biopharma jobs; and more: Welcome back to Endpoints Weekly, your review of the week’s top… #lucidquest #genetherapy #celltherapy https://t.co/6v1LdB0FsL

Gene&Cell Therapy >> FDA wants more data from Abeona Therapeutics as it pushes for BLA: Abeona Therapeutics pushed back plans to submit its gene therapy for a rare skin condition after the FDA asked the company for… #lucidquest #genetherapy #celltherapy https://t.co/zFUUsHFaP3

Gene&Cell Therapy >> Nordic Nanovector to acquire Thor Medical in new merger deal: Shareholders of Nordic Nanovector did not like the first merger partner the Norwegian biotech chose last fall. So the company went… #lucidquest #genetherapy #celltherapy https://t.co/sytPOBwJ5H

Gene&Cell Therapy >> Editas reports early sickle cell disease, beta thalassemia data for CRISPR therapy: Editas Medicine narrowed its pipeline and laid off 20% of its workforce at the start of this year in order to… #lucidquest #genetherapy #celltherapy https://t.co/7wCZZcvbWX

Gene&Cell Therapy >> December approval decision set for first CRISPR gene editing therapy as Vertex, CRISPR report sickle cell win: Nearly 11 years ago, scientists programmed a pair of molecular scissors to make… #lucidquest #genetherapy #celltherapy https://t.co/GMN7qFOQIy

Gene&Cell Therapy >> Alcami appoints new CEO as former chief Patrick Walsh announces retirement: Patrick Walsh Alcami, a North Carolina-based contract manufacturer, tapped a new CEO earlier this week as former… #lucidquest #genetherapy #celltherapy https://t.co/XgtWV3QOKZ

Gene&Cell Therapy >> Manufacturing roundup: EuroAPI to invest $50M+ in Hungary site; WuXi to expand German facility: Active pharmaceutical ingredient manufacturer EuroAPI is looking to make a €50 million ($53.4… #lucidquest #genetherapy #celltherapy https://t.co/0nC4j5Nloy

Gene&Cell Therapy >> Astellas to revisit fatal neuromuscular condition in partnership with startup Kate Therapeutics: Four years ago, a biotech company presented data so powerful it made scientists cry. Speaking… #lucidquest #genetherapy #celltherapy https://t.co/wHhARJt9GU

Gene&Cell Therapy >> Acepodia's off-the-shelf cell therapies get another $100M for oncology trials: California and Taipei biotech Acepodia has lined up another six-figure funding round to take its off-the-shelf cell… #lucidquest #genetherapy #celltherapy https://t.co/5NmktAkPk0

Gene&Cell Therapy >> Biogen cuts PhIII Parkinson’s program over ‘long timeline’ : Biogen is calling it quits on a late-stage Parkinson’s trial as part of an ongoing R&D reorganization. The Cambridge, MA-based… #lucidquest #genetherapy #celltherapy https://t.co/GBAVBlpv4M

Gene&Cell Therapy >> Exclusive: Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO for oncology spinout: Thaminda Ramanayake Affini-T is looking for a partner as its KRAS-targeting T… #lucidquest #genetherapy #celltherapy https://t.co/njN8gFEn8j

Gene&Cell Therapy >> Precision BioSciences to meet with FDA after touting allogeneic CAR-T win: Precision BioSciences is now touting new data from a Phase I/II trial, saying that it has identified a dosing regimen… #lucidquest #genetherapy #celltherapy https://t.co/ZL3gv5bwEd

Gene&Cell Therapy >> Seres receives $125M payment from Nestlé; French biotech teases early-stage eye disease data: Seres Therapeutics, a microbiome-focused biotech, has been handed a $125 million milestone payment… #lucidquest #genetherapy #celltherapy https://t.co/gpqp5YmBlf

Gene&Cell Therapy >> RA Capital-backed non-viral gene therapy startup Summation Bio to shut down: As a string of new gene therapy startups aims to create treatments without the go-to shuttling method of an AAV virus,… #lucidquest #genetherapy #celltherapy https://t.co/349euNlUHu

Gene&Cell Therapy >> With cash running low, cell therapy company Idogen looks to sell off platform before liquidation: Small cell therapy company Idogen will have to liquidate the company if another solution isn’t… #lucidquest #genetherapy #celltherapy https://t.co/Et0a3spbu1

Gene&Cell Therapy >> BenchSci raises $70M Series D for drug discovery software; Zentalis touts PhIb ovarian cancer data: Canada’s BenchSci has raised $70 million in a Series D round designed to scale its AI drug… #lucidquest #genetherapy #celltherapy https://t.co/zfm9Sztk9i

Gene&Cell Therapy >> Artiva boasts early NK cell therapy results, giving lifeline to partner Affimed: Artiva Biotherapeutics reported early data on its off-the-shelf NK cell therapy in combination with rituximab,… #lucidquest #genetherapy #celltherapy https://t.co/9dSzBIq7uC

Gene&Cell Therapy >> Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle: Outpace Bio, a Seattle-based biotech that aims to create cell therapies, has cemented its presence in the Emerald… #lucidquest #genetherapy #celltherapy https://t.co/CtE2Xdhbp0

Gene&Cell Therapy >> Boehringer Ingelheim extends 2020 collab with Oxford BioTherapeutics; European biotechs claim positive PhI I/O data: Oxford BioTherapeutics said Thursday that it has extended its second… #lucidquest #genetherapy #celltherapy https://t.co/yQMrHE0Af6

Gene&Cell Therapy >> UCB inks license agreement with ClearPoint Neuro for epilepsy and neurodegeneration gene therapy research: UCB may not have any gene therapy candidates on the market or publicly in its pipeline,… #lucidquest #genetherapy #celltherapy https://t.co/WpKOKwiIaH